Intimation pertaining to closure of trading window

Date: September 24, 2026 To, To, Sr. General Manager Sr. General Manager Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street Bandra Kurla Complex Mumbai – 400001 Bandra (E), Mumbai – 400 051 BSE Scrip Code: 544319 NSE Symbol: SENORES Subject: Intimation of Trading Window Closure Dear Sir/Madam, Pursuant to the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (“SEBI PIT Regulations”) as amended from time to time and Company's Code of Conduct (“Code”) for prevention of insider trading, the trading window, for trading in the securities of the Company by the Directors, Promoters, Designated Persons and their immediate relatives, shall remain closed from October 01, 2026 till 48 hours after announcement / declaration of Un-audited Financial Results for quarter and half year ending on September 30, 2026. In view of the above, all the Directors, Promoters, Designated Persons and their immediate relatives are advised not to trade in the securities of the Company during the aforesaid period of closure of trading window. The date of Board Meeting for approving the Un-audited Financial Results for quarter and half year ending on September 30, 2026, will be intimated separately in due course. You are requested to take the same on record and acknowledge the receipt of the same. Thanking you. For Senores Pharmaceuticals Limited Shilpa Sharma Company Secretary & Compliance Officer Membership Number: A34516 Senores Pharmaceuticals Limited 1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park, Ambali Bopal Road, Ahmedabad-380054, Gujarat, India P: +91 79 2999 9857 | E: info@senorespharma.com W: www.senorespharma.com | CIN No.: L24290GJ2017PLC100263